Primidone ( DrugBank: Primidone )
1 disease
告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
2 | 筋萎縮性側索硬化症 | 1 |
2. 筋萎縮性側索硬化症
臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | ChiCTR2200058224 | 2022-05-01 | 2022-04-03 | The treatment of primidone for bulbar dysfunction in amyotrophic lateral sclerosis: A randomized, double-blind, cross-over controlled clinical trial | The treatment of primidone for bulbar dysfunction in amyotrophic lateral sclerosis: A randomized, double-blind, cross-over controlled clinical trial | amyotrophic lateral sclerosis | Group A:phase I: primidone 60 mg/d; Wash-out period: no intervention; phase II: placebo control;Group B:phase I: placebo control; Wash-out period: no intervention; phase II: primidone 60 mg/d; | The First People's Hospital of Yichang | NULL | Pending | 18 | Both | Group A:50;Group B:50; | Phase 2 | China |